Call for Abstracts closed
This conference will provide an opportunity for interested researchers, clinicians, academics and people directly affected by Machado-Joseph Disease (MJD), also known as Spinocerebellar Ataxia Type 3 (SCA3), to exchange innovative knowledge and share stories of hope and inspiration. We are particularly interested to hear from clinicians and researchers working with marginalised populations and/or in resource limited settings. The aim is to foster strong partnerships for the future of MJD research. Early career researchers are strongly encouraged to submit abstracts.
- Contextual Care: issues and innovation in MJD care in low resourced and culturally complex contexts
- Clinical Research & Practice
- Clinical Trials: questions, access, equity and issues concerning clinical trials for MJD
- Natural History and cohort studies
- Diagnostic, therapeutic and rehabilitative services - engagement and delivery of services
- Pre-clinical and Drug therapies: information, advances and collaboration
- Gene therapies: current knowledge, innovations and best practice/ethical considerations
- Drug compounds and other therapies
- Disease mechanisms: Pathogenesis, biomarker studies
- General/other: for presentations not captured by the streams titles above
Abstracts will be reviewed for final selection and allocation to the appropriate stream by the Scientific Planning Committee on the following criteria:
Primary Criteria (applicable to all streams):
- Suitability to conference theme- does the topic fit into one of the above streams?
- Current relevance- does it benefit the MJD research and client community?
- New knowledge- does it advance the existing body of literature?
- Quality- is it high quality scientifically, scholarly, and/or in other ways?
- Ethics- is the approach respectful of the participant(s) and/or subject and confidentiality protected?
Secondary Criteria (where applicable):
- Health/quality of life improvement- does it promote an understanding of the range of health determinants and multi-disciplinary approaches which impact the health and wellbeing of people with MJD?
- Cultural sensitivity- does it acknowledge a contextual cross cultural approach where applicable?
Special consideration will be given to abstracts which address equity issues in clinical trials and/or health care service delivery.
Abstracts will be considered for oral and poster presentations based on author preference. Authors may submit more than one abstract. Abstracts should be no greater than 350 words.
Please Note: You may also submit your abstract to the main meeting - International Ataxia Research Conference (IARC) 2019, which is encouraged. If your abstract is selected for IARC as a poster presentation, you may also be selected to present your research as an oral presentation at the MJD Research satellite meeting.
It is required that you submit your abstract directly to the MJD Research Conference Abstract Submissions Page for consideration to present at the satellite meeting.
For oral presentations: Authors should be prepared for 15 minute presentations (including 5 minutes for questions).
There is the possibility of flexible presentation times depending on the number and quality of abstracts received.
For posters: Authors should be available during poster sessions to discuss the poster’s content with conference attendees and for 3- 5 minute oral presentations (with a maximum of 2 slides) during ‘fire talk’ sessions. The number of poster presenters offered a ‘fire talk’ may be limited depending on the number of abstracts received. Posters can be either landscape or portrait, A0 in size (841 x 1189 mm / 33.1 x 46.8 in).